Population-based and self-selecting adult participants of this Australian cohort study (n=281) completed survey questions exploring varied outcome measures related to tinnitus. Primary outcomes assessed communication of initial tinnitus diagnoses and subsequent treatment offering, with participants rating their satisfaction at the...
The authors investigate the occupations of adults with cochlear implants (CI) compared to those with hearing impairment without implants (HI) and individuals with normal hearing (NH). A total of 204 participants were included: 98 CI users, 52 HI individuals and...
This is a retrospective study of patients with external auditory canal cholesteatoma (EACC) managed at a single tertiary centre from 1 January 2010 to 1 January 2021. Ninety patients (100 ears) were included. Mean age at diagnosis was 56+23 years....
Puma Soundproofing exports 60% of its turnover – currently over 5,000 booths have been successfully installed in hospitals, clinics and universities across more than 50 countries worldwide.
Otinova for Otitis Externa or ‘swimmers ear’. When Associate Professor and senior physician Mats Engstrom came across Otinova in his ENT clinic in Lakarhuset, Uppsala, he collected detailed information about the patients who tried the preparation.
Neuromod Devices, the global technology business behind scientifically proven tinnitus treatment technology, Lenire, closed €30m funding to expand availability of the groundbreaking tinnitus intervention.
You would work as part of a team and primarily deliver high quality teaching and training across a range of programmes based on your area of specialism
Grow your own business, look after your private and NHS customers, serve your community, create an asset for your family’s future and enjoy the profits of all your hard work.
We are delighted to introduce Amanda Stratford as the new CEO of ENT UK. Amanda, who took over from Katie Nurcombe as CEO on 2 January, comes from a health charity and NHS background, with 20 years of charity sector...
Interacoustics is pleased to announce an update to the popular VisualEyes™ VNG system which adds new data-driven tests designed to enhance the diagnostic evaluation and outcome of dizzy patients. VisualEyes 3.2 offers a new standalone package: VORTEQ™ Functional Assessments which...